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Purpose: To identify the molecular defect causing gelatinous drop-like corneal dystrophy (GDLD) in two Chinese brothers
and report the morphological evaluation of GDLD by laser scanning confocal microscopy and Fourier-domain optical
coherence tomography (OCT).
Methods: Genetic analysis included polymerase chain reaction (PCR) amplification and direct nucleotide sequencing of
the coding region of the tumor-associated calcium signal transducer 2 gene (TACSTD2) in DNA from the two brothers
and their relatives. Laser scanning confocal microscopy and Fourier-domain OCT were performed on the left cornea of
the younger brother.
Results: We report a novel in-frame mutation of TACSTD2, c.526_576del 51, in the two brothers with GDLD. The
identified  molecular  defect  cosegregated  with  the  disease  and  was  not  found  in  50  unaffected  individuals.  The
morphological evaluation on GDLD highlighted pathological observations at the level of epithelium and anterior stroma.
The epithelial cells of GDLD cornea were irregular in shape and often elongated. Large accumulations of brightly reflective
amyloid material was noted within or beneath the epithelium and within the anterior stroma.
Conclusions: The newly identified mutation expands the spectrum of mutations in TACSTD2 that may cause pathological
corneal amyloidosis. Observations by in vivo confocal microscopy and Fourier-domain OCT were consistent with the
histopathologic descriptions of GDLD.
Gelatinous drop-like corneal dystrophy (GDLD; OMIM
204870) is an extremely rare autosomal recessive disease
characterized by the deposition of amyloid material in the
subepithelial  space  of  the  cornea.  It  has  an  estimated
prevalence of 1 in 300,000 in Japan. GDLD patients have also
been observed in India, the United States, Europe, Tunisia,
Turkey, and Vietnam [1]. Clinical manifestations of GDLD
most often appear in the first decade of life with a bilateral,
axial, elevated, mulberry-like gelatinous lesion. The amyloid
depositions in the central cornea, which appear in the early
stage  of  disease,  will  increase  in  number  and  depth  and
coalesce, leading to a progressive opacification of the cornea
and resulting in significant decrease in vision, photophobia,
lacrimation,  and  foreign  body  sensation.  Eventually,
penetrating  or  lamellar  keratoplasty,  photoablation,  or
keratectomy is required to recover corneal clarity and visual
rehabilitation.  Unfortunately,  symptoms  generally  recur
within  a  few  years  after  intervention,  and  repeated
keratoplasties are often performed [2].
Genetic linkage analysis of 20 GDLD families in Japan
established a 2.6 centimorgan (cM) interval on chromosome
1p as the chromosomal segment harboring the putative causal
gene  [3].  Later,  membrane  component,  chromosome  1,
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surface  marker  1  (M1S1),  previously  termed  GA733–1  or
TROP2, was identified as the causative gene located within
this region [4]. M1S1, in agreement with the Human Genome
Organization  (HUGO)  nomenclature,  has  been  renamed
TACSTD2 (tumor-associated calcium signal transducer 2) [5].
TACSTD2 consists of a single exon spanning about 1.8 kb of
genomic DNA. It codes for a protein of 323 amino acids,
which is a monomeric cell surface glycoprotein expressed in
the cornea, multistratified epithelia, and trophoblasts and is
found in most carcinomas with high protein expression levels
[4,6]. The physiologic function of TACSTD2 has not been
completely elucidated, however it is hypothesized that the
protein can act as a calcium signal transducer [6].
Approximately 24 different TACSTD2 mutations have
been reported to date, predominantly in patients from Asia
[7,8]. Herein, we present the clinical, histopathologic, and
genetic assessment of two Chinese brothers with GDLD in
which  a  novel  TACSTD2  mutation  was  identified.  Our
findings add to the allelic heterogeneity of this rare form of
inherited corneal disease.
METHODS
This study was approved by the Institutional Review Board
of the Henan Eye Institute (Zhengzhou, PR China). Informed
consent in accordance with the Declaration of Helsinki was
obtained from the patients and their family members who
participated in this study.
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1580GDLD  case  1—A  39-year-old  Chinese  man  (the
proband) was referred to our department in August 2007 with
bilateral GDLD. He had complaints of defective vision since
childhood. His vision had worsened in the past 10 years. He
had recurrent episodes of lacrimation and photophobia in both
eyes. His visual acuity was limited to counting fingers at 1 m
in  both  eyes  at  the  time  of  presentation.  Under  slit-lamp
examination, the right cornea showed diffuse opacities with
multiple  grayish-white  nodular  elevations  located  in  the
subepithelial area whereas his left eye showed band-shaped
opacities in the interpalpebral area of the cornea with several
gelatinous  prominences  above  the  band-shaped  opacities
(Figure 1A,B). Details of the anterior chamber and lens were
not visualized. In September 2007, we performed a lamellar
keratoplasty on the right eye using a fresh donor cornea. At
the most recent examination, the cornea showed no recurrence
of  GDLD  with  a  best-corrected  visual  acuity  (BCVA)  of
20/40.
GDLD case 2—A 49-year-old man, the elder brother of
the proband, was seen in our department in October 2007 with
bilateral GDLD. He presented with the same symptoms as the
proband. Visual acuity was counting fingers in the right eye
and hand movements in the left eye. The patient didn’t seek
medical  attention  until  this  point.  Examination  revealed
yellowish corneal lesions with an irregular surface throughout
the entire stroma and superficial vascularization in the right
eye whereas his left eye showed the characteristic findings of
GDLD such as multiple milky-white, opaque, semiglobate
prominences (Figure 1C,D).
These two brothers had no significant systemic diseases.
Ophthalmic examinations of their mother and siblings didn’t
reveal any ocular abnormalities, and there were no known
similar familial ocular conditions according to the report from
other  family  members.  The  parents  of  the  brothers  were
unaware of any consanguinity, but both parents came from the
same small village. The village is isolated, and the population
flow is very small.
Mutation  analysis:  Molecular  genetic  analyses  were
performed  on  the  two  brothers  and  the  unaffected  family
members (members I:2, II:1, II:5, III:2, and III:5 from this
family; Figure 2A). Fifty unrelated, healthy Chinese subjects
were examined as controls. Genomic DNA was obtained from
peripheral blood leukocytes according to standard procedures.
For amplification of the single exon of TACSTD2, polymerase
chain reaction (PCR) was performed, and primer pairs were
used as designed by Akhtar et al. [9]. Their sequences are as
follows: TACSTD2 F1: 5′-ACG TGT CCC ACC AAC AAG
AT-3′, R1: 5′-CAG GTA ATA GAT GAG CGT GCG-3′;
TACSTD2 F2: 5′-GGA TGT GTC ACC CAA ATA CCA-3′,
R2:  5′-CTT  GAG  CAG  CAG  ACA  CTT  GGA-3′;  and
TACSTD2 F3: 5′-CCT ACT ACT TCG AGA GGG ACA-3′,
R3: 5′-CAG GAA GCG TGA CTC ACT T-3′. The sizes of
the amplified DNA fragments are 681 bp, 423 bp, and 382 bp,
respectively.
Each polymerase chain reaction was performed in a 50
μl reaction mixture consisting of genomic DNA (100 ng),
dNTP mixture (200 μM), 25 μl 2X GC buffer with MgCl2,
forward and reverse primer (0.1 μM each), and 2.5 U Hotstar
Figure  1.  Slit-lamp  photographs  of
affected  individuals  eyes.  The  left
cornea  of  the  younger  brother  show
band-shaped  opacities  occupying  the
inferior cornea, consisting of yellowish
deposits  (A).  Gelatinous  prominences
were above the band-shaped opacities
(B). Appearance of the right cornea of
the  elder  brother  demonstrates
yellowish corneal lesions with irregular
surface  within  the  entire  stroma  (C).
Grayish-white nodular elevations were
shown in the left cornea of the elder
brother (D).
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Report of cases:Figure 2. Novel TACSTD2 mutation in
the  study  family.  A:  Pedigree  of  the
study family is shown. In the family tree,
squares  indicate  male  and  circles
indicate  female.  Slash  denote  family
member  who  are  deceased  whereas
heavy  shading  denote  the  individuals
who are affected by GDLD. The arrow
indicates the proband. B: The sequence
from the proband, which is at the top,
shows  a  51  bp  deletion  between
nucleotides 526 and 576 in the coding
region of TACSTD2. This homozygous
mutation  was  exclusively  detected  in
affected family members. The normal
sequence of TACSTD2 near codon 176
is shown at the bottom. C: The mutation
was also detected by polymerase chain
reaction-restriction  length  fragment
polymorphism  (PCR-RFLP).  Lane  1,
Sample  from  unaffected  control
individual; lanes 2 through 4, samples
from  family  members;  lane  5,  uncut
amplicons. D: Heterozygous mutation
in TACSTD2 was detected in the study
family. Sequence of the TACSTD2 gene
around codon 257 in the proband shows
heterozygous  772–
783del(ATCTATTACCTG)+772insT.
Double-wave  peaks  were  seen  after
codon  257  in  sense  strands  or  after
codon 262 in antisense strands resulting
from  non-matching  of  nucleotide
sequence in two alleles (top). Sequence
analysis of TACSTD2 near codon 257 in
sense or codon 262 in antisense strands
detected in a healthy control (bottom).
Molecular Vision 2009; 15:1580-1588 <http://www.molvis.org/molvis/v15/a168> © 2009 Molecular Vision
1582Taq polymerase (Qiagen, Hilden, Germany). GC buffer was
provided  by  Takara  Biotechnology  (Dalian)  Co.  Ltd
(Liaoning, China) and designed for amplification of templates
having  complex  secondary  structure  or  high  GC  content.
Amplification reactions were performed under the following
conditions: 4 min of denaturation at 95 °C followed by 30
cycles of denaturation at 94 °C for 30 s, annealing at 50−55 °C
for 30 s, extension at 72 °C for 30 s, and a further extension
step at 72 °C for 8 min in a Gene-Amp PCR system 9700
(Perkin-Elmer Applied Biosystems, Foster City, CA). For
direct  sequencing,  PCR  products  were  purified  using  the
QIAquick PCR purification kit (Qiagen), cycle sequenced
with a Big Dye Terminator cycle sequencing kit (Perkin-
Elmer Applied Biosystems), and directly sequenced on both
strands using an automatic DNA sequencer (ABI Prism 377
Genetic  Analyzer;  Perkin-Elmer  Applied  Biosystems)
according to the manufacturer’s instructions.
Nucleotide sequences were compared with the published
cDNA sequence of TACSTD2 (GenBank accession number
NM_002353.2). The novel mutation found in the TACSTD2
coding region was confirmed by PCR-restriction fragment
length polymorphism (PCR-RFLP) analysis.
Histopathologic analysis: Corneal tissue, excised at the
time of a lamellar keratoplasty in the younger brother, was
available for histopathologic examination. The corneal button
was  sectioned  and  analyzed  with  light  microscopy  after
staining with hematoxylin and eosin (H&E), periodic acid-
Schiff (PAS), and Congo red stains.
Confocal  microscopy  and  Fourier-domain  OCT
analysis:  In  this  study,  we  coupled  in  vivo  confocal
microscopy  and  Fourier-domain  optical  coherence
tomography (OCT) to evaluate the morphological changes of
the cornea in a patient with GDLD and compared the results
with the clinical ocular surface findings and histopathologic
examination.
After a detailed explanation, a laser scanning in vivo
confocal microscopy with a diode laser with a wavelength of
670  nm  (HRT3/Rostock  Cornea  Module;  Heidelberg
Engineering, Heidelberg, Germany) was performed on the left
cornea of the younger brother. Two-dimensional confocal
images  of  the  different  corneal  layers  were  acquired.
Subsequently,  the  left  cornea  of  the  younger  brother  was
scanned three times with two scan patterns, the line scan and
the cross-line scan, by a high-speed, high-resolution, Fourier-
domain  optical  coherence  tomography  (Optovue  Inc.,
Fremont,  CA).We  chose  the  best  of  the  three  scans  for
analysis.
RESULTS
Mutation analysis: Two sequence variations were identified
in TACSTD2 of the brothers with GDLD. In the two brothers
(case1-II:7 and case2-II:3), we found a 51 bp deletion between
nucleotides 526 and 576 (526–576del 51) in coding region of
TACSTD2 (Figure 2B), which led to a loss of 17 amino acids
at codons 176–192. This novel mutation was observed in the
homozygous  state  in  the  affected  brothers  and  in  a
heterozygous state in the proband’s mother, daughter, and
nephew (I:2, III:5, and III:2). This mutation was confirmed
using the restriction enzyme, BstXI (Takara Biotechnology).
PCR products (681 bp) harboring the homozygous mutation
were digested with BstXI. Wild amplicons were digested into
468 bp and 213 bp DNA fragments while the mutant could
not be cut as the mutation erased the enzyme recognition site.
Therefore,  digested  amplicons  from  patients  with  a
homozygous mutation had only one electrophoretic band (681
bp), but those from heterozygous unaffected family members
yielded 681 bp, 468 bp, and 213 bp fragments (Figure 2C).
Sequencing of the 382 bp PCR product of TACSTD2 in
the affected brothers revealed a 12 bp deletion from nucleotide
position  772–783  [772–783del(ATCTATTACCTG)],
resulting in a loss of four amino acids at codons 258–261.
Also, in the place of the missing sequence, an insertion of T
(772insT) was found. This combined mutation was confirmed
by analysis of both the forward and reverse sequence data and
was heterozygous in the patients and the unaffected family
members (I:2, III:5, and III:2; Figure 2D).
None of the above identified mutations were detected in
the control population of 50 unaffected, unrelated, healthy
volunteers as determined by restriction enzyme digest.
Histopathologic  analysis:  Histopathologic  analysis  of  the
corneal button that was excised during a lamellar keratoplasty
from  the  proband  revealed  areas  of  irregular  epithelial
hyperplasia, areas of epithelial atrophy, the destruction of
Bowman’s layer, and large deposits of eosinophilic material
that had positive staining of PAS and Congo red. The corneal
stroma was vascularized and showed a chronic inflammatory
cell  infiltrate  (Figure  3A-C).  The  deposits  manifested
different patterns depending on their position. Subepithelial
deposits formed massive clumps that appeared to push up the
epithelial  layer  to  form  mulberry-like  patterns.  Higher
magnification of the area just beneath the epithelium revealed
band-like sections with many spikes vertical to the basement
line or amyloid materials. All the Congo red-positive deposits
within  or  beneath  the  epithelium  and  within  the  anterior
stroma manifested birefringence under polarized light (Figure
3D,E).
Confocal  microscopy  and  Fourier-domain  OCT  analysis:
Laser scanning in vivo confocal microscopy revealed that the
epithelial cells of the GDLD cornea were irregular in shape
and often elongated. This was in contrast to normal epithelial
cells, which appeared polygonal in form and were 30–40 µm
in  diameter  (Figure  4A,B).  Furthermore,  a  mild
disorganization of the overall epithelial architecture was noted
(Figure  4C,D).  The  in  vivo  laser  scanning  confocal
microscopic image at the level of the Bowman’s membrane
showed  a  very  small  number  of  sub-basal  nerves  with
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1583Figure 3. Photography of corneal histological features of the proband. A: A hematoxylin and eosin stained section shows epithelial atrophy,
epithelial hyperplasia, and the considerable extent of the subepithelial and superficial stromal deposits of eosinophilic material. Original
magnification 100X. B: Nodular subepithelial amorphous deposits stain positive with periodic acid-Schiff. Original magnification 100X. C:
Congo red-positive accumulations were within or beneath the epithelium and within the anterior stroma. In some areas, Congo red-positive
deposits accumulated to form gelatinous drop-like masses. Original magnification 100X. D: Higher magnification revealed band-like structures
with a spike-like pattern just beneath the epithelium. Original magnification 400X. E: Congo red staining under polarized light revealed typical
apple-green birefringence in epithelial and subepithelial regions, indicative of amyloid. Original magnification 100X.
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1584increased  background  intensity  (Figure  4E,F).  Large
accumulations of brightly reflective amyloid materials were
noted within or beneath the epithelium and within the anterior
stroma. The nuclei of keratocytes were poorly identifiable
because  keratocytes  were  embedded  in  the  extracellular
matrix of increased reflectivity (Figure 4G,H). No evident
abnormalities could be detected in posterior cornea (Figure
4I,J) .
The  images  acquired  from  Fourier-domain  OCT,
showing the reflectivity of all corneal layers, indicated that
the main presence of amyloid deposits was localized within
the anterior stroma, extending from the epithelium layer to a
depth of 150–230 µm and that the highest density of amyloid
deposits seemed to be mainly in the anterior stroma, which is
within the first 100 µm of the corneal depth (Figure 5).
DISCUSSION
The autosomal recessive form of gelatinous drop-like corneal
dystrophy  is  a  rare  eye  disorder  caused  by  mutations  in
TACSTD2.  Molecular  genetic  analysis  of  patients  from
diverse ethnic backgrounds showed both genetic and allelic
heterogeneity  for  GDLD  [10-14].  Herein,  we  report  the
molecular  genetic  analysis  of  TACSTD2  in  two  Chinese
brothers with GDLD in which two TACSTD2 mutations were
identified.
A 526–576del51 mutation and a 772–783del+772insT
mutation were revealed by direct sequencing of the coding
region of TACSTD2 in these two brothers. The 772–783del
+772insT mutation was described in a Vietnamese patient
who was homozygous for this mutation [13]. In contrast, our
patients and their family members (I:2, III:5, and III:2) were
all heterozygous for this mutation in TACSTD2. Our patients
are from an isolated village in the central region of China and
have no ethnic relationship with the Vietnamese. However,
the 526–576del51 mutation was homozygous in the GDLD-
affected brothers and heterozygous in their family members
(I:2, III:5, and III:2), indicating that it was cosegregated with
the phenotype. Such genetic alteration was excluded in the
control  population.  Thus,  this  homozygous  mutation  was
expected to cause GDLD in the two brothers. To date, only
three patients with genetically mapped GDLD were reported
from  China  having  the  homozygous  or  compound
heterozygous mutation [7,14]. The previous Chinese GDLD
patient with the Q118X/Y184C mutation lived in northern
China  whose  ethnic  relationship  with  the  Japanese  was
unclear. Two other GDLD patients are from two unrelated
consanguineous  families  in  the  southern  and  southeastern
regions of China. The two different mutations identified in
these  two  patients  are  both  homozygous  frame-shift
mutations, and the sites of the mutations are unique. These
consisted of two insertions/deletions of a nucleotide, causing
a shift in the translational reading frame and introducing a
premature  termination  codon  not  far  downstream  of  the
mutation site.
The 40 kDa TACSTD2 protein contains an epidermal
growth factor (EGF)-like repeat, a thyroglobulin type 1A (TY)
repeat,  a  transmembrane  domain  (TM),  and  a
phosphatidylinositol  (PIP2)-binding  site,  harboring
phosphorylatable  serine  and  threonine  residues  near  the
COOH-terminus. The single transmembrane segment extends
from position 275–298 of the amino acid sequence [4]. In our
GDLD patients, the dysfunction of TACSTD2 is likely due to
an in-frame deletion of 17 amino acids (L176_A192del) in
TACSTD2. This in-frame deletion of TACSTD2 arises in a
highly conserved region corresponding to the helix-turn-helix
(HTH) configuration, and it is predicted to alter the ability of
TACSTD2 to bind its target DNA sequences. The HTH is a
short motif made up of an alpha-helix, a connecting turn, and
a second helix, which specifically interacts with the DNA and
is  known  as  the  recognition  helix.  The  two  alpha-helices
extend from the domain surface and constitute a convex unit
able to fit into the major groove of DNA [15-17]. Crystal
structure  analysis  of  the  human  TACSTD2  protein
demonstrated that codons L176–A192 lie on the first alpha-
helix and connecting turn of the HTH motif. Therefore, it is
likely that the in-frame deletion of these codons in the two
brothers  interferes  with  the  correct  folding  of  the  HTH
configuration  in  TACSTD2.  GDLD  could  be  due  to  the
absence of functional TACSTD2 and/or the effects of the
shortened protein.
Approximately 24 different GDLD-causing mutations in
TACSTD2  have  been  documented  to  date.  Most  of  the
mutations  reported  have  been  missense  and  nonsense
mutations. The mutations of nonsense and frame-shift are
generally  expected  to  have  global  detrimental  effects  on
protein  function.  However,  mutations  causing  amino  acid
alterations  may  be  more  informative  with  regard  to  the
biochemical reason for development of a disease phenotype.
With regards to GDLD, 8 of the 24 reported putative disease-
causing mutations produce amino acid alterations (excluding
M1R, which affects initiation of protein synthesis). The novel
17 amino acid deletion mutation identified in our study was
within a region between the TY and TM domains, signifying
the  importance  of  these  regions  in  relation  to  TACSTD2
function. The function of the region between the TY and TM
domains is unknown, but the mutations in the TY domain may
affect its role as a protease inhibitor and thus affect amyloid
deposition [18].
Nowadays, in vivo confocal microscopy and OCT have
offered  useful  tools  in  the  study  of  normal  and  diseased
cornea. However, no data have been published with respect to
the in vivo confocal microscopy and/or OCT appearance of
this disease. Our morphological evaluation on GDLD by laser
scanning in vivo confocal microscopy and Fourier-domain
OCT further clarifies the pathological changes of this disease.
In the presented case, which is clinically diagnosed as GDLD,
laser  scanning  in  vivo  confocal  microscopy  and  Fourier-
domain  OCT  highlighted  observations  at  the  level  of  the
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1585Figure 4. Confocal microscopy analysis of the proband’s left cornea. Superficial epithelial cells (A, B), wing cells (C, D), Bowman’s membrane
(E,F), anterior keratocytes (G, H), and posterior keratocytes (I, J) on GDLD (A, C, E, G, I) and normal cornea (B, D, F, H, J) are displayed.
A: The epithelial cells of GDLD cornea were irregular in shape and often elongated. B: Normal epithelial cells are shown. C: The overall
epithelial architecture was destroyed. D: Normal wing cells are shown for comparison. E: At the level of the Bowman’s membrane, a very
small number of sub-basal nerves were detectable. F: Normal Bowman’s membrane is shown. G: Large accumulations of brightly reflective
amyloid materials were noted within the anterior stroma. H: Normal anterior keratocytes are shown for comparison. I: Posterior keratocytes
of the GDLD patient. J: Posterior keratocytes of a normal control.
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1586epithelium and anterior stroma, was consistent with the results
of the previous histological study of GDLD [19]. However,
observations obtained by these two techniques are neither
completely comparable with established clinical observations
by  the  slit-lamp  biomicroscope  nor  with  the  structural
descriptions of established ex vivo microscopic techniques. In
summary, our data add a novel mutation identified in two
Chinese brothers with GDLD to the existing spectrum of
TACSTD2 mutations.
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